Literature DB >> 10539378

Efficacy and safety of a fixed-combination homeopathic therapy for sinusitis.

M Adler.   

Abstract

The efficacy and safety of a fixed-combination homeopathic medication (Sinusitis PMD) consisting of Lobaria pulmonaria, Luffa operculata, and potassium dichromate were investigated in an open-label practice-based study of 119 male and female patients, 12 to 57 years of age, with clinical signs of acute sinusitis not previously treated. At the first visit, after a mean of 4.1 days of treatment, secretolysis had increased significantly and typical sinusitis symptoms, such as headache, pressure pain at nerve exit points, and irritating cough, were reduced. Ninety-nine patients received only the test medication. Twenty patients were able to discontinue concomitant medication at the first visit. Only one patient needed an antibiotic. The average treatment duration was 2 weeks. At the end of treatment, 81.5% of patients described themselves as symptom free or significantly improved. Adverse drug effects were not reported.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10539378

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  3 in total

1.  Recently published papers: out with the old and in with the new ... then something new for the old!

Authors:  Simone Carbert; Richard Venn
Journal:  Crit Care       Date:  2005-05-12       Impact factor: 9.097

2.  Immunology and homeopathy. 4. Clinical studies-part 1.

Authors:  Paolo Bellavite; Riccardo Ortolani; Francesco Pontarollo; Valeria Piasere; Giovanni Benato; Anita Conforti
Journal:  Evid Based Complement Alternat Med       Date:  2006-07-05       Impact factor: 2.629

3.  Luffa operculata effects on the epithelium of frog palate: histological features.

Authors:  Mônica Aidar Menon-Miyake; Paulo Hilário Nascimento Saldiva; Geraldo Lorenzi-Filho; Marcelo Alves Ferreira; Ossamu Butugan; Regiani Carvalho de Oliveira
Journal:  Braz J Otorhinolaryngol       Date:  2005-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.